FDA identifies more bogus cancer drugs (Avastin - labeled as Altuzan) in U.S | Reuters

FDA identifies more bogus cancer drugs in U.S | Reuters

Tue Apr 3, 2012 8:31pm EDT
 

(Reuters) - The U.S. Food and Drug Administration on Tuesday said it has identified a new batch of counterfeit cancer drugs distributed in the United States and is urging doctors to avoid using the products, which contain no active ingredient.
The fake versions of Swiss drugmaker Roche's widely used cancer drug Avastin are labeled as Altuzan, which is the brand name that Avastin is sold under in Turkey, and do not contain the drug's active ingredient, bevacizumab.